BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu W, Chen S, Wang X, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases. Pharmacol Ther 2021;217:107659. [PMID: 32800789 DOI: 10.1016/j.pharmthera.2020.107659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Wang F, Wang X, Fan S, Li Y, Xu M, Hu H, Liu K, Zheng B, Wang L, Zhang H, Li J, Li W, Zhang W, Hu Z, Cao R, Zhuang X, Wang M, Zhong W. Antiviral effects and tissue exposure of tetrandrine against SARS-CoV-2 infection and COVID-19. MedComm (2020) 2023;4:e206. [PMID: 36699286 DOI: 10.1002/mco2.206] [Reference Citation Analysis]
2 Liang D, Li Q, Du L, Dou G. Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules 2022;27. [PMID: 36558061 DOI: 10.3390/molecules27248933] [Reference Citation Analysis]
3 Li J, Li X, Zhou S, Wang Y, Lu Y, Wang Q, Zhao F. Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL. Mol Med 2022;28:141. [DOI: 10.1186/s10020-022-00568-4] [Reference Citation Analysis]
4 Russell T, Gangotia D, Barry G. Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication. Biomedicine & Pharmacotherapy 2022;156:113850. [DOI: 10.1016/j.biopha.2022.113850] [Reference Citation Analysis]
5 Xia M, Liu D, Liu H, Peng L, Yang D, Tang C, Chen G, Liu Y, Liu H. Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation. Front Med 2022;9:881322. [DOI: 10.3389/fmed.2022.881322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gao J, Zheng M, Wu X, Zhang H, Su H, Dang Y, Ma M, Wang F, Xu J, Chen L, Liu T, Chen J, Zhang F, Yang L, Xu Q, Hu X, Wang H, Fei Y, Chen C, Liu H. CDK inhibitor Palbociclib targets STING to alleviate autoinflammation. EMBO Rep 2022;23:e53932. [PMID: 35403787 DOI: 10.15252/embr.202153932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yu J, Chen H, Xu J, Zhou P. Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases. Mol Cell Biochem 2022. [PMID: 35034257 DOI: 10.1007/s11010-022-04354-y] [Reference Citation Analysis]
8 Nguyen VK, Kou KGM. The biology and total syntheses of bisbenzylisoquinoline alkaloids. Org Biomol Chem 2021;19:7535-43. [PMID: 34524341 DOI: 10.1039/d1ob00812a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]